AbbVie, Gilead Sciences, Pfizer, and Roche are among the companies that must cut a check to the U.S. government. Those companies have Medicare-covered medicines whose prices rose faster than inflation and according to a…
Continue Reading
Greenway Health’s Intergy Practice Management (PM) solution was recently ranked in the top five as a ‘Best in KLAS’ solution. This recognition was, in part, thanks to improvements that were made from direct user…
Continue Reading
Seagen, the biotech company Pfizer is buying for $43 billion, is considered a pioneer in the class of cancer drugs called antibody drug conjugates. But the first ADC to reach the market wasn’t a…
Continue Reading
Heart health issues are intermittent and often asymptomatic, leaving issues undetected with individuals unaware of any underlying problem. This presents itself in places where we least expect them, for example Danish soccer player Christian…
Continue Reading
Ask people what is wrong with the healthcare system and you’ll get 10 different answers. But if there’s one thing that everyone can get behind it’s that we need to accelerate innovation and cut…
Continue Reading
The telehealth flexibilities allowed during the Covid-19 public health emergency greatly expanded access to healthcare services. But after the public health emergency ends, it’s ultimately up to Congress to further extend these flexibilities, said…
Continue Reading
The Department of Justice filed a lawsuit Monday against Rite Aid, accusing the pharmacy chain of filling hundreds of thousands of opioid prescriptions that had “obvious, and often multiple, red flags.”
Rite Aid is one…
Novo Nordisk is slashing prices of several insulin products by up to 75% amid growing political scrutiny on the prices of these older but still expensive diabetes medicines. The announcement Tuesday comes two weeks…
Continue Reading
Life sciences organizations have access to more data than ever before. When they leverage that existing data during their research and development (R&D) process, organizations can drive more efficient drug development.
Innovation and regulatory approval…
The worsening mental health crisis among children and adolescents is the most pressing issue affecting patient safety, according to ECRI.
Each year, the nonprofit creates a list of the industry’s top ten patient safety concerns….
